Skip to main content
$2.96Today:- (-)1Y −74.73%

As of Oct 26, 2026 close

Market cap
$4.00M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.52$14.13
Volume (live)
-
Avg. volume (3M)
17.12K

DNA X (SONM) Income Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), DNA X posted a net loss of $20.66M, compared with a net loss of $33.65M a year earlier.

DNA X Income Statement Analysis

Values in millions USD

Scroll to see more
DNA X, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue0.0058.3093.6369.8354.5763.99116.25135.6759.03
Cost of Revenue4.3048.3874.3158.2148.1648.7881.7487.5838.72
Gross Profit-4.309.9219.3211.626.4115.3134.5148.0920.31
Operating Expenses
Research & Development0.0014.241.777.9717.7016.2226.0623.2513.01
Selling, General & Administrative5.413.1017.0417.9426.7220.2530.0919.4514.07
Operating Expenses5.413.1018.8125.9144.4242.9356.8942.7027.08
Operating Income-5.41-3.100.51-14.29-38.00-27.61-22.385.39-6.77
Other Income/Expense
Interest Income0.000.000.000.000.000.000.000.000.00
Interest Expense1.490.030.020.100.00-0.761.521.830.82
Other Income/Expense-1.060.25-0.210.39-0.46-0.05-2.07-3.36-1.62
Income
Income Before Tax-7.96-2.880.28-13.90-38.46-30.45-24.452.03-8.39
Income Tax Expense0.000.230.370.180.17-0.521.390.750.13
Net Income-20.66-33.65-0.09-14.09-38.63-29.93-25.831.28-8.52
Net Income - Continuous Operations-7.96-2.88-0.09-14.09-38.63-29.93-25.831.28-8.52
Net Income - Discontinued Operations-12.70-30.77-------
EBITDA-2.170.702.51-11.43-36.33-26.53-19.405.71-6.25
EBIT-6.47-2.850.30-13.81-38.00-29.26---
Depreciation & Amortization4.303.562.212.382.132.733.531.851.32
Earnings Per Share
Basic EPS-29.00-128.00--88.00-735.00-11664.00-2500.00-798.00-1381.00
Diluted EPS-29.00-128.00--88.00-735.00-1166.00-2500.00-798.00-1381.00
Basic Shares Outstanding0.720.260.240.160.050.000.010.010.01
Diluted Shares Outstanding0.720.260.240.160.050.000.010.010.01

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About DNA X Financial Statements

Is DNA X profitable?

No. DNA X reported a net loss of $20.66M in fiscal 2025. In fiscal 2024 it lost $33.65M.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition